What is the recommended diagnostic workup for cervicitis?

Diagnostic Workup for Cervicitis

The diagnostic workup for cervicitis should include nucleic acid amplification testing (NAAT) for Chlamydia trachomatis and Neisseria gonorrhoeae on cervical or urine samples, evaluation for bacterial vaginosis and trichomoniasis, and assessment for signs of pelvic inflammatory disease (PID). 1

Clinical Diagnosis

Cervicitis is diagnosed by the presence of either or both of these major signs:

• Purulent or mucopurulent endocervical exudate visible in the endocervical canal or on an endocervical swab specimen
• Sustained endocervical bleeding easily induced by gentle passage of a cotton swab through the cervical os 1

Additional supportive findings include:

• Leukorrhea (>10 WBC per high-power field on microscopic examination of vaginal fluid) - this has high negative predictive value for cervical inflammation 1
• Symptoms of abnormal vaginal discharge or intermenstrual vaginal bleeding (though cervicitis is frequently asymptomatic) 1

Essential Laboratory Testing

Primary Testing (Mandatory)

NAAT for C. trachomatis and N. gonorrhoeae - These are the preferred tests and can be performed on either cervical or urine samples 1. This is critical because cervicitis may signal upper genital tract infection (endometritis), requiring assessment for PID 1.

Secondary Testing (Strongly Recommended)

1. Bacterial vaginosis evaluation - Should be assessed and treated if present 1

2. Trichomoniasis testing - Because microscopy has only ~50% sensitivity for T. vaginalis, symptomatic women with cervicitis and negative microscopy should receive further testing via culture or antigen-based detection 1

3. Vaginal wet mount - A finding of >10 WBC in vaginal fluid (in the absence of trichomoniasis) may indicate endocervical inflammation specifically caused by C. trachomatis or N. gonorrhoeae 1

Tests with Limited Utility

Several diagnostic approaches have limited clinical value:

• Endocervical Gram stain for polymorphonuclear leukocytes - Not standardized, has low positive predictive value for C. trachomatis and N. gonorrhoeae, and is unavailable in most clinical settings 1

• Gram stain for gram-negative intracellular diplococci (GNID) - While specific for gonococcal infection, it is insensitive (observed in only 50% of infected women) 1

• HSV-2 testing - Although HSV-2 infection has been associated with cervicitis, the utility of specific testing (culture or serology) in this setting is unclear 1

• Mycoplasma genitalium testing - Standardized diagnostic tests are not commercially available 1, though emerging evidence suggests this pathogen may be relevant 2

Assessment for Complications

All women with new cervicitis must be assessed for signs of PID because cervicitis can indicate upper genital tract infection 1. This is crucial for preventing serious sequelae including ectopic pregnancy and infertility.

Common Pitfalls

1. Over-reliance on clinical signs alone - Many women with C. trachomatis or N. gonorrhoeae do not have mucopurulent cervicitis 3, so absence of clinical signs does not rule out infection

2. Inadequate trichomoniasis testing - Microscopy alone misses 50% of cases; additional testing is needed when microscopy is negative but suspicion remains 1

3. Failure to test comprehensively - In the majority of cervicitis cases, no organism is isolated 1, but this doesn't negate the need for thorough testing to identify treatable causes

4. Missing bacterial vaginosis - Recent data shows BV is detected in approximately 30% of non-chlamydial/non-gonococcal cervicitis cases and is increasing in prevalence 2